γH2AX as a molecular marker of aging and disease

Epigenetics

Volumn 5, Issue 2, 2010, Pages 129-136

  Mah, Li Jeen ^a,b   El Osta, Assam ^a,b   Karagiannis, Tom C ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Aging; Carcinogenesis; Chromatin modification; DNA damage; Double strand break; Repair; H2AX

Indexed keywords

HISTONE ACETYLTRANSFERASE; BIOLOGICAL MARKER; HISTONE;

ACETYLATION; CHROMATIN; DNA SEQUENCE; EPIGENETICS; GENETIC EPISTASIS; GENOME; NUCLEOSOME; REVIEW; YEAST; AGING; ANIMAL; DNA DAMAGE; GENERAL ASPECTS OF DISEASE; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY;

AGING; ANIMALS; BIOLOGICAL MARKERS; DISEASE; DNA DAMAGE; HISTONES; HUMANS; INFLAMMATION;

EID: 77954022035     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.5.2.11080     Document Type: Review

References (123)

1. Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 2001; 27:247.
2. Lieber MR, Ma Y, Pannicke U, Schwarz K. Mechanism and regulation of human non-homologous DNA end-joining. Nat Rev Mol Cell Biol 2003; 4:712-20.
3. Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP. MDC1 Directly Binds Phosphorylated Histone H2AX to Regulate Cellular Responses to DNA Double-Strand Breaks. Cell 2005; 123:1213-26.
4. Kobayashi J, Iwabuchi K, Miyagawa K, Sonoda E, Suzuki K, Takata M, Tauchi H. Current topics in DNA double-strand break repair. J Radiat Res 2008; 49:93-103.
5. Mahaney B, Meek K, Lees-Miller S. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem J 2009; 417:639-50.
6. Natarajan AT, Palitti F. DNA repair and chromosomal alterations. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2008; 657:3-7.
7. Rothkamm K, Kruger I, Thompson LH, Lobrich M. Pathways of DNA Double-Strand Break Repair during the Mammalian Cell Cycle. Mol Cell Biol 2003; 23:5706-15.
8. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273:5858-68.
9. Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM. Quantitative detection of (125) IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat Res 2002; 158:486-92.
10. Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W. Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev 2002; 12:162-9.
11. Fernandez-Capetillo O, Chen H-T, Celeste A, Ward I, Romanienko PJ, Morales JC, et al. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol 2002; 4:993.
12. Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E, Anderson CW. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol Cell Biol 1992; 12:5041-9.
13. Karlsson K, Stenerlöw B. Focus formation of DNA repair proteins in normal and repair-deficient cells irradiated with high-LET ions. Radiat Res 2004; 161:517-27.
14. Leatherbarrow EL, Harper JV, Cucinotta FA, O'Neill P. Induction and quantification of γ-H2AX foci following low and high LET-irradiation. Int J Radiat Biol 2006; 82:111-8.
15. Stiff T, O'Driscoll M, Rief N, Iwabuchi K, Lobrich M, Jeggo PA. ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation. Cancer Res 2004; 64:2390-6.
16. Falck J, Coates J, Jackson SP. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 2005; 434:605-11.
17. Fei P, El-Deiry WS. p53 and radiation responses. Oncogene 2003; 22:5774-83.
18. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, et al. A ribonucleotide reductase gene involved in a p53-dependent cell cycle checkpoint for DNA damage. Nature 2000; 404:42-9.
19. Stiff T, Walker S, Cerosaletti K, Goodarzi A, Petermann E, Concannon P, et al. ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J 2006; 25:5775-82.
20. Ward IM, Minn K, Chen J. UV-induced Ataxia-telangiectasia-mutated and Rad3-related (ATR) Activation Requires Replication Stress. J Biol Chem 2004; 279:9677-80.
21. Bouquet F, Muller C, Salles B. The loss of gammaH2AX signal is a marker of DNA double strand breaks repair only at low levels of DNA damage. Cell Cycle 2006; 5:1116-22.
22. Banath JP, MacPhail SH, Olive PL. Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res 2004; 64:7144-9.
23. Xie A, Puget N, Shim I, Odate S, Jarzyna I, Bassing C, et al. Control of sister chromatid recombination by histone H2AX. Mol Cell 2004; 16:1017-25.
24. Celeste A, Petersen S, Romanienko P, Fernandez-Capetillo O, Chen H, Sedelnikova O, et al. Genomic instability in mice lacking histone H2AX. Science 2002; 296:922-7.
25. Savic V, Sanborn K, Orange J, Bassing C. Chipping away at gamma-H2AX foci. Cell Cycle 2009; 8:3285-90.
26. Harikrishnan KN, Karagiannis TC, Chow MZ, El-Osta A. Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments. Cell Cycle 2008; 7:468-76.
27. Karagiannis TC, Harikrishnan KN, El-Osta A. Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments. Oncogene 2007; 26:3963-71.
28. Kinner A, Wu W, Staudt C, Iliakis G. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucl Acids Res 2008; 36:5678-94.
29. Bhogal N, Jalali F, Bristow RG. Microscopic imaging of DNA repair foci in irradiated normal tissues. Int J Radiat Biol 2009.
30. Rogakou EP, Boon C, Redon C, Bonner WM. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 1999; 146:905-16.
31. Rothkamm K, Lobrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci USA 2003; 100:5057-62.
32. Chen HT, Bhandoola A, Difilippantonio MJ, Zhu J, Brown MJ, Tai X, et al. Response to RAG-Mediated V(D)J Cleavage by NBS1 and {gamma}-H2AX. Science 2000; 290:1962-4.
33. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H, et al. Rearrangement of the MLL Gene in Acute Lymphoblastic and Acute Myeloid Leukemias with 11q23 Chromosomal Translocations. N Engl J Med 1993; 329:909-14.
34. Novik KL, Spinelli JJ, MacArthur AC, Shumansky K, Sipahimalani P, Leach S, et al. Genetic Variation in H2AFX Contributes to Risk of Non-Hodgkin Lymphoma. Cancer Epidemiol Biomarkers Prev 2007; 16:1098-106.
35. Pui CH, Chessells JM, Camitta B, Baruchel A, Biondi A, Boyett JM, et al. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia 2003; 17:700-6.
36. Rubnitz J, Behm F, Downing J. 11q23 rearrangements in acute leukemia. Leukemia 1996; 10:74-82.
37. Dickey J, Redon C, Nakamura A, Baird B, Sedelnikova O, Bonner W. H2AX: functional roles and potential applications. Chromosoma 2009;118:683-92.
38. Ong DCT, Ho YM, Rudduck C, Chin K, Kuo WL, Lie DKH, et al. LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer. Oncogene 2009; 28:4189-200.
39. Srivastava N, Gochhait S, Gupta P, Bamezai R. Copy number alterations of the H2AFX gene in sporadic breast cancer patients. Cancer Genet Cytogenet 2008; 180:121-8.
40. Parikh R, White J, Huang X, Schoppy D, Baysal B, Baskaran R, et al. Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma. Genes Chromosomes Cancer 2007; 46:761-75.
41. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005; 434:864-70.
42. Gorgoulis VG, Vassiliou L-VF, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005; 434:907-13.
43. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, et al. Tumour biology: Senescence in premalignant tumours. Nature 2005; 436:642.
44. Bassing C, Suh H, Ferguson D, Chua K, Manis J, Eckersdorff M, et al. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors Cell 2003; 114:359-70.
45. Celeste A, Difilippantonio S, Difilippantonio MJ, Fernandez-Capetillo O, Pilch DR, Sedelnikova OA, et al. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 2003; 114:371-83.
46. Bassing CH. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc Natl Acad Sci USA 2002; 99:8173-8.
47. Zha S, Sekiguchi J, Brush JW, Bassing CH, Alt FW. Complementary functions of ATM and H2AX in development and suppression of genomic instability. Proc Nat Acad Sci 2008; 105:9302-6.
48. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396:643.
49. Coleman W, Tsongalis G. The role of genomic instability in human carcinogenesis. Anticancer Res 1999; 19:4645-64.
50. Nakamura A, Redon C, Sedelnikova O. Where did they come from? The origin of endogenous gamma-H2AX foci in tumor cells. Cell Cycle 2009; 8:2324.
51. Yu T, MacPhail SH, Banath JP, Klokov D, Olive PL. Endogenous expression of phosphorylated histone H2AX in tumors in relation to DNA double-strand breaks and genomic instability. DNA Repair 2006; 5:935-46.
52. Warters RL, Adamson PJ, Pond CD, Leachman SA. Melanoma Cells Express Elevated Levels of Phosphorylated Histone H2AX Foci. J Investig Dermatol 2005; 124:807-17.
53. Takai H, Smogorzewska A, de Lange T. DNA damage foci at dysfunctional telomeres. Curr Biol 2003; 13:1549-56.
54. Nowsheen S, Wukovich RL, Aziz K, Kalogerinis PT, Richardson CC, Panayiotidis MI, et al. Accumulation of oxidatively induced clustered DNA lesions in human tumor tissues. Mutat Res 2009; 674:131-6.
55. Sedelnikova OA, Bonner WM. gamma H2AX in cancer cells: A potential biomarker for cancer diagnostics, prediction and recurrence. Cell Cycle 2006; 5:2909-13.
56. Li H, Mitchell J, Hasty P. DNA double-strand breaks: a potential causative factor for mammalian aging?. Mech Ageing Dev 2008; 129:416-24.
57. Aubert G, Lansdorp PM. Telomeres and Aging. Physiol Rev 2008; 88:557-79.
58. Sinclair DA, Oberdoerffer P. The ageing epigenome: Damaged beyond repair? Ageing Res Rev 2009; 8:189-98.
59. Colavitti R, Finkel T. Reactive oxygen species as mediators of cellular senescence. IUBMB Life 2005; 57:277-81.
60. Sedelnikova OA, Horikawa I, Redon C, Nakamura A, Zimonjic DB, Popescu NC, Bonner WM. Delayed kinetics of DNA double-strand break processing in normal and pathological aging. Aging Cell 2008; 7:89-100.
61. Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner WM, Barrett JC. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol 2004; 6:168-70.
62. Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner WM, Barrett JC. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol 2004; 6:168.
63. Nakamura A, Chiang YJ, Hathcock K, Horikawa I, Sedelnikova O, Hodes R, Bonner W. Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence. Epigenetics Chromatin 2008; 1:6.
64. Bakkenist CJ, Drissi R, Wu J, Kastan MB, Dome JS. Disappearance of the Telomere Dysfunction-Induced Stress Response in Fully Senescent Cells. Cancer Res 2004; 64:3748-52.
65. Fagagna FdAd, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, von Zglinicki T, et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003; 426:194-8.
66. Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 2005; 6:611-22.
67. Ostler E, Wallis C, Sheerin A, Faragher R. A model for the phenotypic presentation of Werner's syndrome. Exp Gerontol 2002; 37:285-92.
68. Bohr V. Deficient DNA repair in the human progeroid disorder, Werner syndrome. Mutat Res 2005; 577:252-9.
69. Gorbunova V, Seluanov A. Making ends meet in old age: DSB repair and aging. Mech Ageing Dev 2005; 126:621-8.
70. Seluanov A, Danek J, Hause N, Gorbunova V. Changes in the level and distribution of Ku proteins during cellular senescence. DNA Repair 2007; 6:1740-8.
71. Neuman MG. Immune dysfunction in inflammatory bowel disease. Transl Res 2007; 149:173-86.
72. Arnett H, Viney J. Gatekeepers of intestinal inflammation. Inflamm Res 2009; Epub ahead of print.
73. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007; 117:514-21.
74. Maeda H, Akaike T. Nitric oxide and oxygen radicals in infection, inflammation and cancer. Biochemistry 1998; 63:854-65.
75. Forrester J, Bick-Forrester J. Persistence of inflammatory cytokines cause a spectrum of chronic progressive diseases: implications for therapy. Med Hypotheses 2005; 65:227-31.
76. Galkina E, Ley K. Immune and Inflammatory Mechanisms of Atherosclerosis*. Annu Rev Immunol 2009; 27:165-97.
77. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000; 21:361-70.
78. Nichols GJ, Schaack J, Ornelles DA. Widespread Phosphorylation of Histone H2AX by Species C Adenovirus Infection Requires Viral DNA Replication. J Virol 2009; 83:5987-98.
79. McConnell B, Yang V. The Role of Inflammation in the Pathogenesis of Colorectal Cancer. Curr Colorectal Cancer Rep 2009; 5:69-74.
80. Risques RA, Lai LA, Brentnall TA, Li L, Feng Z, Gallaher J, et al. Ulcerative Colitis Is a Disease of Accelerated Colon Aging: Evidence From Telomere Attrition and DNA Damage. Gastroenterology 2008; 135:410-8.
81. Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Koprowicz KM, Bronner MP, Brentnall TA. DNA Fingerprinting Abnormalities Can Distinguish Ulcerative Colitis Patients with Dysplasia and Cancer from Those Who Are Dysplasia/Cancer-Free. Am J Pathol 2003; 162:665-72.
82. Seril DN, Liao J, Yang G-Y, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 2003; 24:353-62.
83. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860-7.
84. Blanco D, Vicent S, Fraga M, Fernandez-Garcia I, Freire J, Lujambio A, et al. Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathway. Neoplasia 2007; 9:840-52.
85. Dickey JS, Baird BJ, Redon CE, Sokolov MV, Sedelnikova OA, Bonner WM. Intercellular Communication of Cellular Stress Monitored by {gamma}-H2AX Induction. Carcinogenesis 2009; 192.
86. Nagasawa H, Little J. Bystander effect for chromosomal aberrations induced in wild-type and repair deficient CHO cells by low fluences of alpha particles. Mutat Res 2002; 508:121-9.
87. Prise KM, Folkard M, Michael BB. A review of the bystander effect and its implications for low-dose exposure. Radiat Prot Dosimetry 2003; 104:347-55.
88. Little J. Cellular radiation effects and the bystander response. Mutat Res 2006; 597:113-8.
89. Sokolov MV, Smilenov LB, Hall EJ, Panyutin IG, Bonner WM, Sedelnikova OA. Ionizing radiation induces DNA double-strand breaks in bystander primary human fibroblasts. Oncogene 2005; 24:7257-65.
90. Burdak-Rothkamm S, Short SC, Folkard M, Rothkamm K, Prise KM. ATR-dependent radiation-induced [gamma]H2AX foci in bystander primary human astrocytes and glioma cells. Oncogene 2006; 26:993-1002.
91. Smilenov LB, Hall EJ, Bonner WM, Sedelnikova OA. A microbeam study of DNA double-strand breaks in bystander primary human fibroblasts. Radiat Prot Dosimetry. 2006; 122:256-9.
92. Sokolov MV, Dickey JS, Bonner WM, Sedelnikova OA. gamma-H2AX in bystander cells-Not just a radiation-triggered event, a cellular response to stress mediated by intercellular communication. Cell Cycle 2007; 6:2210-2.
93. Hu B, Wu L, Han W, Zhang L, Chen S, Xu A, et al. The time and spatial effects of bystander response in mammalian cells induced by low dose radiation. Carcinogenesis 2006; 27:245-51.
94. Hei TK, Zhou H, Ivanov VN, Hong M, Lieberman HB, Brenner DJ, et al. Mechanism of radiation-induced bystander effects: a unifying model. J Pharm Pharmacol 2008; 60:943-50.
95. Rajakariar R, Yaqoob MM, Gilroy DW. COX-2 in Inflammation and Resolution. Mol Interv 2006; 6:199-207.
96. Hayashi T, Kusunoki Y, Hakoda M, Morishita Y, Kubo Y, Maki M, et al. Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors. Int J Radiat Biol 2003; 79:129-36.
97. Neriishi K, Nakashima E, Delongchamp R. Persistent subclinical inflammation among A-bomb survivors. Int J Radiat Biol 2001; 77:475-82.
98. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003; 3:276-85.
99. Han W, Wu L, Chen S, Bao L, Zhang L, Jiang E, et al. Constitutive nitric oxide acting as a possible intercellular signaling molecule in the initiation of radiation-induced DNA double strand breaks in non-irradiated bystander cells. Oncogene 2007; 26:2330-9.
100. Yang H, Asaad N, Held KD. Medium-mediated intercellular communication is involved in bystander responses of X-ray-irradiated normal human fibroblasts 2005; 24:2096-103.
101. Allan SM, Rothwell NJ. Inflammation in central nervous system injury. Philos Trans R Soc Lond B Biol Sci 2003; 358:1669-77.
102. Lucas S-M, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol 2006; 147:232-40.
103. del Zoppo G, Ginis I, Hallenbeck M, Iadecola C, Wang X, Feuerstein G. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 2000; 10:95-112.
104. McGeer PL, McGeer EG. Local Neuroinflammation and the Progression of Alzheimer's Disease. J Neurovirol 2002; 8:529-38.
105. Hanisch U. Microglia as a source and target of cytokines. Glia 2002; 40:140-55.
106. Xia W, Han J, Huang G, Ying W. Inflammation in Ischemic Brain Injury: Current Advances and Future Perspectives. Clin Exp Pharmacol Physiol 2009; In press.
107. Grainger DJ. TGF{beta} and atherosclerosis in man. Cardiovasc Res 2007; 74:213-22.
108. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18:655-73.
109. Dhalla N, Golfman L, Takeda S, Takeda N, Nagano M. Evidence for the role of oxidative stress in acute ischemic heart disease: a brief review. Can J Cardiol 1999; 15:587-93.
110. Girotti A. Mechanisms of lipid peroxidation. J Free Radic Biol Med 1985; 1:87-95.
111. Dean RT, Fu S, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 1997; 324:1-18.
112. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39:44-84.
113. Boros P, Bromberg JS. New Cellular and Molecular Immune Pathways in Ischemia/Reperfusion Injury. Am J Transplantation 2006; 6:652-8.
114. Linfert D, Chowdhry T, Rabb H. Lymphocytes and ischemia-reperfusion injury. Transplant Rev 2009; 23:1-10.
115. Liu P. Ischemia-reperfusion-related repair deficit after oxidative stress: implications of faulty transcripts in neuronal sensitivity after brain injury. J Biomed Sci 2003; 10:4-13.
116. Lopez-Neblina F, Toledo AH, Toledo-Pereyra LH. Molecular Biology of Apoptosis in Ischemia and Reperfusion. J Invest Surg 2005; 18:335-50.
117. Yan Z, Hansson G. Innate immunity, macrophage activation and atherosclerosis. Immunol Rev 2007; 219:187-203.
118. Mena S, Ortega A, Estrela J. Oxidative stress in environmental-induced carcinogenesis. Mutat Res 2009; 674:36-44.
119. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of Oxidative Damage in Human Disease. Clin Chem 2006; 52:601-23.
120. Kukreja RC, Hess ML. The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc Res 1992; 26:641-55.
121. Pouget J-P, Mather SJ. General aspects of the cellular response to low- and high-LET radiation. Eur J Nucl Med 2001; 28:541-61.
122. Cadet J, Delatour T, Douki T, Gasparutto D, Pouget J, Ravanat J, Sauvaigo S. Hydroxyl radicals and DNA base damage. Mutat Res 1999; 424:9-21.
123. Sedelnikova OA, Pilch DR, Redon C, Bonner WM. Histone H2AX in DNA damage and repair. Cancer Biol Ther 2003; 2:233-5.